Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Not applicableStudy completedNCT05069545
What this trial is testing

A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice

Who this might be right for
Diabetes Mellitus, Type 1
Novo Nordisk A/S 411
Large-scale testing (Phase 3)Study completedNCT01835431
What this trial is testing

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 362
Post-approval studies (Phase 4)Study completedNCT01438632
What this trial is testing

Pharmacology of Insulin Injected With Jet-injection in Diabetes

Who this might be right for
Diabetes Mellitus
Radboud University Medical Center 24
Not applicableStudy completedNCT00283218
What this trial is testing

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

Who this might be right for
Type 1 Diabetes
University of Aarhus 24
Post-approval studies (Phase 4)Study completedNCT01278160
What this trial is testing

Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 179
Testing effectiveness (Phase 2)Study completedNCT00613951
What this trial is testing

Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 182
Not applicableStudy completedNCT04055480
What this trial is testing

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions

Who this might be right for
Type 1 Diabetes
University of Cambridge 25
Early research (Phase 1)Study completedNCT02089451
What this trial is testing

A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 21
Not applicableStudy completedNCT00698126
What this trial is testing

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 4,099
Large-scale testing (Phase 3)Study completedNCT05802862
What this trial is testing

Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China

Who this might be right for
Diabetes
Sunshine Lake Pharma Co., Ltd. 414
Large-scale testing (Phase 3)Study completedNCT00595374
What this trial is testing

Efficacy and Safety of Insulin Detemir in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 114
Large-scale testing (Phase 3)Study completedNCT03689374
What this trial is testing

A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,274
Not applicableStudy completedNCT04149262
What this trial is testing

Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor

Who this might be right for
Type 1 Diabetes
Aristotle University Of Thessaloniki 44
Not applicableStudy completedNCT01536613
What this trial is testing

Post Marketing Surveillance Study of Biphasic Insulin Aspart 30

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 5,346
Early research (Phase 1)Study completedNCT01620424
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 10
Large-scale testing (Phase 3)Study completedNCT05539872
What this trial is testing

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers

Who this might be right for
PharmacokineticsPharmacodynamics
Amphastar Pharmaceuticals, Inc. 69
Large-scale testing (Phase 3)Ended earlyNCT00331604
What this trial is testing

Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 618
Post-approval studies (Phase 4)Study completedNCT00121966
What this trial is testing

South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Odense University Hospital 400
Not applicableWithdrawnNCT03862690
What this trial is testing

A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S
Not applicableStudy completedNCT04163874
What this trial is testing

Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas

Who this might be right for
Type 1 DiabetesType 1 Diabetes MellitusHyperglycemia, Postprandial
McGill University 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation